Position in PCVX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,902,069
+$28,662,518 QoQ
Shares Held
514,577
+1815.4% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$1,625,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in PCVX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,902,069 | 514,577 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,239,551 | 26,865 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,018,350 | 278,133 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,408,218 | 104,836 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $1,625,500 | 50,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $955,328 | 25,300 | Put | Sole | 2025-05-15 | |
| 2024-09-30 | $8,475,063 | 74,167 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,617,169 | 418,715 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $14,182,960 | 284,000 | Put | Sole | 2023-08-14 | |
| 2022-09-30 | $226,008 | 9,417 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||